No Cover Image

Journal article 11 views 4 downloads

The Evolution and Complications of Long-Term Mechanical Circulatory Support Devices

Christian R. Sargent, Sabrina Ali, Venkat Kanamarlapudi Orcid Logo

Hearts, Volume: 5, Issue: 1, Pages: 105 - 121

Swansea University Author: Venkat Kanamarlapudi Orcid Logo

  • 66726.VoR.pdf

    PDF | Version of Record

    © 2024 by the authors.This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY) license.

    Download (1.31MB)

Check full text

DOI (Published version): 10.3390/hearts5010008

Abstract

Heart failure, a common clinical syndrome caused by functional and structural abnormalities of the heart, affects 64 million people worldwide. Long-term mechanical circulatory support can offer lifesaving treatment for end-stage systolic heart failure patients. However, this treatment is not without...

Full description

Published in: Hearts
ISSN: 2673-3846
Published: MDPI AG 2024
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa66726
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract: Heart failure, a common clinical syndrome caused by functional and structural abnormalities of the heart, affects 64 million people worldwide. Long-term mechanical circulatory support can offer lifesaving treatment for end-stage systolic heart failure patients. However, this treatment is not without complications. This review covers the major complications associated with implantable mechanical circulatory support devices, including strokes, pump thrombosis and gastrointestinal bleeding. These complications were assessed in patients implanted with the following devices: Novacor, HeartMate XVE, CardioWest, Jarvik 2000, HeartMate II, EVAHEART, Incor, VentrAssist, HVAD and HeartMate 3. Complication rates vary among devices and remain despite the introduction of more advanced technology, highlighting the importance of device design and flow patterns. Beyond clinical implications, the cost of complications was explored, highlighting the difference in costs and the need for equitable healthcare, especially with the expected rise in the use of mechanical circulatory support. Future directions include continued improvement through advancements in design and technology to reduce blood stagnation and mitigate high levels of shear stress. Ultimately, these alterations can reduce complications and enhance cost-effectiveness, enhancing both the survival and quality of life for patients receiving mechanical circulatory support.
Keywords: heart failure; mechanical circulatory support; complications; ventricular assist device
College: Faculty of Medicine, Health and Life Sciences
Funders: This research received no external funding.
Issue: 1
Start Page: 105
End Page: 121